• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Summary Elixhauser score interally validated for mortality prediction in older adults

byAndrew LeeandKiera Liblik
September 19, 2022
in Chronic Disease, Public Health
Reading Time: 2 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. The Summary Elixhauser (S-Elixhauser) comorbidity score is internally validated for predicting 30-day and one-year mortality for older adults.

2. The S-Elixhauser comorbidity score has not been adequately externally validated.

Evidence Rating Level: 2 (Good)

Study Rundown: In observational studies, summary comorbidity scores are an important way to describe the effect of comorbidity burden on mortality. The S-Elixhauser score aims to predict in-hospital, 30-day, and one-year mortality in older adults with comorbidities. The most common comorbidities identified were uncomplicated hypertension, chronic pulmonary disease, deficiency anemia, complicated diabetes, and hypothyroidism. Further, 30-day and one-year mortality were strongly associated with metastatic cancer, dementia, congestive heart failure, weight loss, severe renal failure, leukemia, and weight gain. However, one-year mortality was underestimated in those with the highest S-Elixhauser scores. The S-Elixhauser summary score outperformed other comorbidity scores when examining a subset of conditions, including heart failure, chronic obstructive pulmonary disease, and diabetes. The S-Elixhauser summary score may outperform others as it was developed with different weights for each outcome, making it more specific. The limitation to summary risk scores is that they do not always discriminate the severity of disease, whether a patient is undergoing treatment or not, and whether the study population used to develop the scores are representative of the general population.

Click to read the study in the Annals of Internal Medicine

Relevant Reading: Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician’s guide

RELATED REPORTS

VS-041 reduced NT-proBNP after 28 days in a phase 1c HFpEF trial

2MM: Pharma Roundup – First DNA therapy approved which could reduce airway surgeries, novel siRNA targets dual lipid pathways, GLP-1s outperform metformin in prediabetes, and Zolgensma tumor risks under FDA review

FDA approvedFor hypertension: Baxfendy (baxdrostat), May 15, 2026→

In-Depth [retrospective cohort]: This retrospective cohort study examined a population- and outcome-specific weighted comorbidity score aimed at predicting in-hospital, 30-day, and one-year mortality in older adults. A 20% random sample of data from Medicare beneficiaries between 2017 and 2019 was used. The cohort included persons older than age 66 who were hospitalized at least once during the study period. The S-Elixhauser summary score was generated by applying the modified Agency for Healthcare Research and Quality (AHRQ) Elixhauser algorithm to define 38 different comorbidities. Separate multivariable logistic regression models were created for each of the three mortality outcomes. The baseline model for each outcome included race and ethnicity, age, and sex. Concordance statistics (c-statistics) were generated and bias-corrected calculations were completed with a 95% confidence interval (CI). The weights that were generated for the 38 comorbidities for 30-day mortality ranged from -5 for obesity to 12 for metastatic cancer. The S-Elixhauser summary score for 30-day mortality had a c-static of 0.667 (95% CI, 0.666 to 0.667). When external validation was completed, the c-statistic was 0.711 (95% CI, 0.709 to 0.713) for the Elixhauser comorbidity indicators. The individual Elixhauser comorbidity indicators had the highest c-statistic for predicting all three outcomes, 0.711 for 30-day mortality (95% CI, 0.709 to 0.713), 0.658 for in-hospital mortality (95% CI, 0.658 to 0.661), and 0.748 for one-year mortality (95% CI, 0.747 to 0.749). For patients with heart failure, chronic obstructive pulmonary disease, or diabetes, the S-Elixhauser summary score had a c-statistic ranging from 0.657 to 0.732 for predicting 30-day mortality. More research needs to be done to examine the external validity and utility of the S-Elixhauser summary score compared to existing comorbidity scores.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: anemiachronic diseaseChronic Obstructive Pulmonary DiseaseComorbidity scoresdiabetesheart failurehypertensionpublic healthSummary Elixhauser comorbidity score
Previous Post

Neoadjuvant celmiplimab is associated with pathologic response in cutaneous squamous cell carcinoma

Next Post

Study reports improvement in pediatric liver transplant outcomes over past decades

RelatedReports

A heart on one side of a scale balances against a tablet on the other, suggesting evaluation of heart health and medication in cardiology.
2MM Trial Briefs

VS-041 reduced NT-proBNP after 28 days in a phase 1c HFpEF trial

November 13, 2026
A variety of pharmaceutical items including a vial, capsule, molecule model, pill blister pack, petri dish with a pipette, and a graph, symbolizing drug development.
Pharma Roundup

2MM: Pharma Roundup – First DNA therapy approved which could reduce airway surgeries, novel siRNA targets dual lipid pathways, GLP-1s outperform metformin in prediabetes, and Zolgensma tumor risks under FDA review

November 9, 2026
A man is sleeping on his side with a caution symbol and tape beside him, while lung images are in the background, suggesting a focus on sleep and respiratory health.
Cardiology

Increased rapid eye movement (REM) sleep is associated with lower risks of several chronic diseases

September 23, 2026
An illustration featuring blood cells and a vial with pills, representing hemophilia and potential treatments for blood coagulation.
Cardiology

Borderline-low hemoglobin levels linked to increased mortality

September 14, 2026
Next Post

Study reports improvement in pediatric liver transplant outcomes over past decades

Low prevalence of adrenal tumors in the general adult screening population

ABCD2 Score: Predicting Early Stroke Risk After Transient Ischemic Attack (TIA) [Classics Series]

Kocher Criteria differentiates pediatric septic arthritis and transient synovitis of the hip [Classics Series]

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Less social media usage is associated with improved internalizing symptoms in high-risk young adults.
  • AI cardiac MRI analysis marginally outperforms clinicians in predicting all-cause mortality
  • In a phase 3 trial, tirzepatide reduced BMI versus placebo in adolescents with obesity and obesity-related complications
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.